The research team led by Senior Researchers Yoonhee Lee from the Division of Biomedical Technology and Gyogwon Koo from the ...

Daughter cells vary significantly after stress In addition to real-time measurements under the microscope, the researchers examined various endpoints, such as the strength of different stress ...

The FDA has accepted the application for lurbinectedin in combination with atezolizumab as a first-line maintenance treatment for patients with extensive-stage small cell lung cancer.

Sarah J. Aitken is at the Center of Molecular and Cellular Oncology, Yale Cancer Center, New Haven, Connecticut 06511, USA, and in the Department of Pathology, Yale School of Medicine, New Haven ...

Key Takeaways The FDA accepted Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer, granting priority review. Phase 3 IMforte trial showed Zepzelca plus ...